Literature DB >> 8542700

Ewing's sarcoma of the proximal femur.

T A Damron1, F H Sim, M I O'Connor, D J Pritchard, W A Smithson.   

Abstract

The cases of 16 patients with Ewing's sarcoma of the proximal femur treated in the era of multiagent chemotherapy were reviewed, with emphasis on the mechanical problem of tumor involvement in this structurally demanding site. Fourteen patients received chemotherapy and local radiotherapy as the initial primary treatment. One patient had chemotherapy and radiotherapy, followed by wide local resection. One patient had amputation, followed by chemotherapy, for pathologic fracture and extensive soft tissue involvement at presentation. Two local recurrences occurred. Excluding the 2 patients whose femurs were fixed prophylactically, the pathologic fracture rate was 79%. In addition, by excluding the 2 patients who died before fracture, the pathologic fracture rate was 92%. Nonunion occurred in 5 (71%) of the 7 pathologic fractures not treated by resection and required as many as 5 additional surgical procedures to obtain union. At latest followup evaluation (average, 6.3 years), 10 patients had no evidence of disease, 1 was alive with disease, and 5 had died of their disease. Options for management should include primary resection and reconstruction or prophylactic internal fixation after completion of chemotherapy plus or minus radiotherapy.

Entities:  

Mesh:

Year:  1996        PMID: 8542700

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  6 in total

1.  CORR Insights®: do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?

Authors:  Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2014-08-26       Impact factor: 4.176

2.  Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?

Authors:  Gerhard M Hobusch; Iris Noebauer-Huhmann; Christoph Krall; Gerold Holzer
Journal:  Clin Orthop Relat Res       Date:  2014-07-12       Impact factor: 4.176

3.  Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group.

Authors:  Najat C Daw; Nadia N Laack; Elizabeth J McIlvaine; Mark Krailo; Richard B Womer; Linda Granowetter; Holcombe E Grier; Neyssa M Marina; Mark L Bernstein; Mark C Gebhardt; Karen J Marcus; Shailesh M Advani; John H Healey; George D Letson; Richard G Gorlick; R Lor Randall
Journal:  Ann Surg Oncol       Date:  2016-05-23       Impact factor: 5.344

Review 4.  Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.

Authors:  Judith U Cope; Gregory H Reaman; Joseph M Tonning
Journal:  Sarcoma       Date:  2015-05-07

5.  Is There an Association Between Bone Microarchitecture and Fracture in Patients who were Treated for High-grade Osteosarcoma? A Controlled Study at Long-term Follow-up Using High-resolution Peripheral Quantitative CT.

Authors:  Gerold Holzer; Gerhard Hobusch; Stinus Hansen; Lukas Fischer; Janina M Patsch
Journal:  Clin Orthop Relat Res       Date:  2021-11-01       Impact factor: 4.755

6.  What Sport Activity Levels Are Achieved in Patients After Resection and Endoprosthetic Reconstruction for a Proximal Femur Bone Sarcoma?

Authors:  Gerhard M Hobusch; Jakob Bollmann; Stephan E Puchner; Nikolaus W Lang; Jochen G Hofstaetter; Philipp T Funovics; Reinhard Windhager
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.